PIERIS PHARMACEUTICALS, INC. - COM (PIRS)

Historical Portfolio Holders from Q2 2015 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 37.7 M
Holdings value Q1 2024: $6.91 M
Value change Q1 2024: -$139 K
Grand Portfolio weight change Q1 2024: 0%
Number of holders: 36
Number of buys Q1 2024: 13
Number of sells Q1 2024: -12
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 720795103

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	37.7 M	$6.91 M	-$139 K	37	0	$0.18	36
2023 Q4	38.5 M	$7 M	-$734 K	783	11.8 K	$0.18	41
2023 Q3	40.3 M	$12 M	-$1.42 M	1.28 K	19.2 K	$0.30	39
2023 Q2	48.6 M	$8.04 M	-$5.17 M	712	19.3 K	$0.17	44
2023 Q1	34.2 M	$33.4 M	-$1.15 M	5.17 K	93 K	$0.98	57
2022 Q4	35.4 M	$36.8 M	-$195 K	4.26 K	78.3 K	$1.04	60
2022 Q3	34.9 M	$40.1 M	-$1.89 M	0	109 K	$1.15	59
2022 Q2	36.6 M	$68.2 M	-$6.12 M	19 K	183 K	$1.87	62
2022 Q1	37.8 M	$115 M	+$6.16 M	52.1 K	400 K	$3.03	67
2021 Q4	34.2 M	$129 M	+$13.5 M	48 K	493 K	$3.78	71
2021 Q3	31.9 M	$165 M	+$29.2 M	1.59 M	1.46 M	$5.17	72
2021 Q2	26.6 M	$102 M	-$18.1 M	1.15 M	1.18 M	$3.83	71
2021 Q1	31.3 M	$79.9 M	-$3.06 M	0	45 K	$2.57	77
2020 Q4	33.3 M	$83.3 M	+$852 K	56 K	0	$2.50	78
2020 Q3	33 M	$68.4 M	-$5.7 M	44 K	67 K	$2.07	82
2020 Q2	34.3 M	$106 M	-$9.51 M			$3.10	89
2020 Q1	35 M	$79.7 M	+$1.89 M		0	$2.28	81
2019 Q4	35.2 M	$127 M	+$23.5 M	0	80 K	$3.62	91
2019 Q3	28.1 M	$95.7 M	-$863 K	249 K	344 K	$3.41	93
2019 Q2	27.2 M	$128 M	-$2.18 M			$4.70	87
2019 Q1	29 M	$97.1 M	-$17.4 M	0		$3.35	88
2018 Q4	34.5 M	$91.7 M	-$10 M	84 K		$2.66	91
2018 Q3	35.4 M	$198 M	+$2.04 M	363 K		$5.60	100
2018 Q2	35.1 M	$178 M	-$8.98 M	486 K	0	$5.07	110
2018 Q1	33.3 M	$227 M	+$71.6 M	962 K	167 K	$6.82	108
2017 Q4	23.7 M	$179 M	+$8.2 M	156 K		$7.55	88
2017 Q3	22.6 M	$130 M	-$17.1 K	95 K		$5.76	65
2017 Q2	22.5 M	$114 M	+$16 M			$5.06	47
2017 Q1	19.4 M	$50.5 M	-$148 K			$2.60	26
2016 Q4	20.1 M	$28.3 M	-$555 K			$1.40	23
2016 Q3	20.5 M	$37.4 M	+$1.42 M			$1.83	29
2016 Q2	19.7 M	$31.7 M	+$3.7 M			$1.61	24
2016 Q1	17.4 M	$33.1 M	-$591 K			$1.90	15
2015 Q4	17.7 M	$40.5 M	-$1.37 M			$2.29	18
2015 Q3	18.5 M	$33.8 M	-$1.49 M			$1.83	13
2015 Q2	16.5 M	$45.3 M	+$45.3 M			$2.75	11